Compare companies
Pick 2–4 companies for a side-by-side spec sheet.
Selected: 1 / 4
Side by side
| Field | Bioptimus |
|---|---|
| Categories | |
| HQ | Paris, France |
| Founded | 2024 |
| Latest valuation | undisclosed (Series A+ 2024) |
| Annual Recurring Revenue (ARR) | — |
| Funding to date | $76M |
| Headcount | undisclosed |
| Profitability | — |
| Status | active |
| Pricing tier | enterprise |
| Description | Bioptimus builds universal foundation AI models for biology, integrating data across molecular to organismal scales to accelerate drug discovery and precision medicine. The company released H-Optimus-0, a foundational model for pathology trained on over 500,000 histopathology slides, with plans to launch M-Optimus, a multi-scale, multi-modal model simulating complex biological processes. |